Cleared Traditional

iSWAB-Respiratory Tract Sample Collection Media-Extraction Less (iSWAB-RC-EL) (K221802) - FDA 510(k) Clearance

Class II Microbiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K221802 · Mawi Dna Technologies · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2023
Decision
286d
Days
Class 2
Risk

K221802 is an FDA 510(k) clearance for the iSWAB-Respiratory Tract Sample Collection Media-Extraction Less (iSWAB-RC-EL). Classified as Microbial Nucleic Acid Storage And Stabilization Device (product code QBD), Class II - Special Controls.

Submitted by Mawi Dna Technologies (Hayward, US). The FDA issued a Cleared decision on April 3, 2023 after a review of 286 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.2950 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Mawi Dna Technologies devices

Submission Details

510(k) Number K221802 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 21, 2022
Decision Date April 03, 2023
Days to Decision 286 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
184d slower than avg
Panel avg: 102d · This submission: 286d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code QBD Microbial Nucleic Acid Storage And Stabilization Device
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.2950
Definition Molecular Transport Media Is A Device Intended For The Stabilization And Transportation Of Nucleic Acids From Unprocessed Human Samples Suspected Of Containing Infectious Material.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - QBD Microbial Nucleic Acid Storage And Stabilization Device

All 16
Devices cleared under the same product code (QBD) and FDA review panel - the closest regulatory comparables to K221802.
Sample preservation solution
K212878 · Zhejiang Gene Science Co., Ltd. · Apr 2024
DNA/RNA Shield SafeCollect Saliva Collection kit
K231013 · Zymo Research · Sep 2023
CLEARinse CTS Specimen Collection and Transport System
K221664 · Aardvark Medical, Inc. · Jul 2023
Spectrum Saliva Collection Device
K223497 · Spectrum Solutions, LLC · Feb 2023
Biosci™ Inactivated Transport Medium, Biosci™ ITM
K220059 · Shenzhen Dakewe Bio-Engineering Co., Ltd. · Jan 2023
Dasky Disposable Sampling Tube (Model name: VSM02)
K211675 · Ningbo Dasky Life Science Co., Ltd. · Aug 2022